Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France

Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer

NCT06907771 ·Status: RECRUITING

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

NCT06084195 ·Status: RECRUITING ·Phase: NA

Prognostic and Predictive Biomarkers in Ovarian Cancers

NCT03010124 ·Status: RECRUITING ·Phase: NA

Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer

NCT02408536 ·Status: UNKNOWN

Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer

NCT06553612 ·Status: RECRUITING ·Phase: NA

Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma

NCT06969833 ·Status: RECRUITING ·Phase: NA

Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients

NCT01905163 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve

NCT00712452 ·Status: TERMINATED ·Phase: NA

Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer

NCT03220932 ·Status: UNKNOWN ·Phase: PHASE3

Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm

NCT01461850 ·Status: COMPLETED ·Phase: PHASE3

Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019.

NCT04573933 ·Status: COMPLETED

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

NCT00349505 ·Status: UNKNOWN ·Phase: PHASE2

Platino-resistance in Ovarian Cancer

NCT03954171 ·Status: RECRUITING ·Phase: NA

A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer

NCT02344095 ·Status: COMPLETED ·Phase: PHASE1

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response

NCT03831230 ·Status: COMPLETED

Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer

NCT03448354 ·Status: UNKNOWN ·Phase: NA

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

NCT06312124 ·Status: RECRUITING ·Phase: NA

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

NCT00043472 ·Status: COMPLETED

Study of Circulating Tumoral DNA in Ovarian Cancer

NCT01350908 ·Status: COMPLETED ·Phase: NA

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

NCT00517621 ·Status: COMPLETED ·Phase: PHASE2

Genomic BRCA and Extensive ovArian Cancer Testing

NCT04027868 ·Status: COMPLETED

Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer

NCT05523804 ·Status: UNKNOWN

Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer

NCT07031908 ·Status: NOT_YET_RECRUITING

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

NCT05500391 ·Status: RECRUITING ·Phase: PHASE2

Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma

NCT05364905 ·Status: COMPLETED